Immunology and Radiotherapy

Stem cell Immunology

In this regard, the field of oncology seems to be at an inflexion point: how do we identify and remove cancerous cells responsible for disease relapse, metastasis, and progression In addition, the understanding and utilization of normal hematopoietic and lymphoid stem cells could open alternate avenues to more effectively re-engineer and direct T cells against CSCs.  Cancer “stem cells” as a new category of targets for immune intervention, for both solid and hematologic malignancies. Therapeutic platforms based on stem cells: hematopoietic stem cells, reprogrammed pluripotent stem cells, stem cell-like memory T cells and tumor-derived stem cells.